Streptococcal brain abscess: analysis of clinical features in 20 patients

Surg Neurol. 2001 Sep;56(3):189-94. doi: 10.1016/s0090-3019(01)00551-1.

Abstract

Background: To assess the clinical features and therapeutic outcomes of brain abscess caused by streptococci.

Methods: Twenty patients, 18 males and 2 females, aged 3 to 76 years, collected over a 14-year period, have been identified at Kaohsiung Chang Gung Memorial Hospital.

Results: Among these 20 patients, 13 had viridans streptococci infection alone, one had non-A, non-B, and non-D streptococci infection alone, and the other 6 had mixed infections each including streptococci. The locations of all of the abscesses were supratentorial. Among these patients, 18 had a single abscess and 2 had multiple abscesses. Underlying conditions were common in our patients, including head trauma, heart disease, otopharyngeal infection, and medical procedures. Nineteen patients were treated surgically and 1 was treated with antibiotics alone. Nineteen survived and 1 died, with an overall mortality rate of 5%.

Conclusion: The clinical presentations and underlying conditions varied according to the different streptococcal species. Streptococcal brain abscesses accounted for 17% of our cases with brain abscesses, and 30% of our streptococcal infections had polymicrobial infections. Although streptococcal brain abscesses were commonly associated with otopharyngeal infections or infectious endocarditis, they also appeared to be often related to neurosurgical events or medical procedures in recent years. Based on our study, prognosis is favorable with early diagnosis and prompt treatment.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Brain Abscess / diagnosis*
  • Brain Abscess / etiology*
  • Brain Abscess / therapy
  • Causality
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Streptococcal Infections / complications*
  • Streptococcal Infections / diagnosis*
  • Streptococcal Infections / therapy
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents